“Start-ups Which Allow Patients More Self-Determination Can Achieve Much”

Dr. Rouven Westphal, Managing Partner and Managing Director at Hasso Plattner Ventures, has extensive experience in the financing of technological companies by business angels and/or VC companies. Dr. Westphal personally invested in IT start-ups, some of which are already traded on the U.S. and European stock exchange markets. Since 2006, he has been responsible for B2B as a partner at Hasso Plattner Venture Capital and teaches Entrepreneurship at the Hasso Plattner Institute in Potsdam-Babelsberg. In this interview, he talks about his investment strategies, opportunities for founders and the cooperation between HPI and HHL.

How does digitalization affect your investment strategies? 

We focus on enterprise and infrastructure software at HPC and Hasso Plattner Ventures. One of the reasons is the ongoing digitalization, for instance, in small and medium-sized companies, in addition to our extensive expertise and the strong network. Our portfolio companies, such as Vera Technologies in California, greatly benefit from these developments.

Where do you currently see good opportunities for founders, specifically in the field of health care? 

Start-ups which cooperate with applications such as Gesundheitscloud (health cloud) can move and achieve great things by providing services which allow patients more self-determination.

Where do you see the benefits of the cooperation between HPI and HHL?

I think the greatest benefit arises when the IT systems engineering students from HPI join forces with the business students from HHL, for instance, as a part of HHL’s student consulting projects or through the joint HPI-HHL Startup Bootcamps, and later found a start-up together.

» “Banking Is Personal and Digital”

» How Artificial Intelligence Disrupt Current Industries

» 3 Key Points to Improve the Digital Economy in Germany

About the Author

Lis Schulz
Online Marketing Manager at HHL